Skip to content
eHealthTutorial — Research Peptide Reviews
Experimental endocrine peptide

GnRH/LH signaling research

Kisspeptin-10 (Kisspeptin)

Kisspeptin-10 is a ten-residue fragment of the kisspeptin family studied for effects on reproductive hormone signaling. It is not interchangeable with kisspeptin-54 used in other clinical studies.

Open calculator Explore the research
Generic research visual — not a commercial product
Compound typeTen-amino-acid kisspeptin fragment
Evidence baseSmall human endocrine experiments
Regulatory contextInvestigational / Not FDA-approved
Page purposeResearch and calculation

Compound calculator

Kisspeptin-10 (Kisspeptin) reconstitution calculator

Enter the values printed on your vial and the liquid volume you added to calculate concentration, liquid volume, and the corresponding mark on a U-100 syringe scale.

Selected peptide or compoundKisspeptin-10 (Kisspeptin)
Enter the total amount printed on the vial.
mL
Enter the liquid volume added in milliliters.
You provide this amount; the calculator does not select or recommend it.
Scale reference only; confirm the markings on the physical syringe.

Your Kisspeptin-10 (Kisspeptin) calculation appears here

Enter the three required values to see the mathematical result.

This calculator performs arithmetic using values you enter. It does not select or recommend an amount, schedule, treatment, preparation method, or method of administration.

Research overview

What is Kisspeptin-10 (Kisspeptin)?

Kisspeptin is a family of peptides that interact with the KISS1 receptor and help regulate GnRH release. Kisspeptin-10 denotes a short C-terminal fragment; the longer kisspeptin-54 is a distinct investigated molecule. Similar names do not make doses, duration, trial outcomes, or products equivalent.

What has research examined?

An endocrine study in men measured LH pulse frequency and related hormone responses after kisspeptin-10 under a small experimental design. Some fertility studies instead examined kisspeptin-54, which cannot be cited as proof for a kisspeptin-10 vial. FDA has flagged immunogenicity, peptide aggregation/impurity concerns, and insufficient safety data for proposed compounded routes of kisspeptin-10.

Important limitation

Hormone-response endpoints do not establish treatment of reproductive disorders or safety of repeated exposure. Kisspeptin-54 trial findings are not kisspeptin-10 outcomes. No fertility treatment, amount, preparation, or use is advised.

Research references

Calculation boundary

The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.